LitAlert ~~ GeneLit.com

    • Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).
    • Omran M, Tham E, Brandberg Y, Ahlström H, Lundgren C, Paulsson-Karlsson Y, Kuchinskaya E, Silander G, Rosén A, Persson F, Leonhardt H, Stenmark-Askmalm M, Berg J, van Westen D, Bajalica-Lagercrantz S, Blomqvist L, on behalf of the Swedish Clinical TP53 Study Group (SweClinTP53).
    • Cancers (Basel). 2022 Jan 13;14(2):380. doi: 10.3390/cancers14020380.
    • YouTube as an information source on BRCA mutations: implications for patients and professionals.
    • Laforet PE, Yalamanchili B, Hillyer GC, Basch CH.
    • J Community Genet. 2022 Jan 13. doi: 10.1007/s12687-022-00576-1. Epub ahead of print.
    • Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.
    • Kerlikowske K, Chen S, Golmakani MK, Sprague BL, Tice JA, Tosteson ANA, Rauscher GH, Henderson LM, Buist DSM, Lee JM, Gard CC, Miglioretti DL.
    • J Natl Cancer Inst. 2022 Jan 13:djac008. doi: 10.1093/jnci/djac008. Epub ahead of print.

    Commentary:

    Towards Using Breast Cancer Risk Prediction Models for Guiding Screening Decisions.

    • CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival.
    • Minguillón J, Ramírez MJ, Rovirosa L, Bustamante-Madrid P, Camps-Fajol C, Ruiz de Garibay G, Shimelis H, Montanuy H, Pujol R, Hernandez G, Bogliolo M, Castillo P, Soucy P, Martrat G, Gómez A, Cuadras D, García MJ, Gayarre J, CIMBA, Lázaro C, Benítez J, Couch FJ, Pujana MA, Surrallés J.
    • Cancers (Basel). 2022 Jan 12;14(2):353. doi: 10.3390/cancers14020353.
    • Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.
    • Rajagopal T, Seshachalam A, Jothi A, Rathnam KK, Talluri S, Venkatabalasubranian S, Dunna NR.
    • Mol Biol Rep. 2022 Jan 12. doi: 10.1007/s11033-022-07129-2. Epub ahead of print.
    • Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk-reducing surgeries in BRCA mutation carriers.
    • Vasigh M, Eslami B, Elahi A, Kaviani A, Shirkoohi R, Majidzadeh K, Nazarian N, Omranipour R.
    • Mol Genet Genomic Med. 2022 Jan 12:e1867. doi: 10.1002/mgg3.1867. Epub ahead of print.
    • BRCA1 Variant Assessment Using a Simple Analytic Assay.
    • Kim DM, Feilotter HE, Davey SK.
    • J Appl Lab Med. 2022 Jan 11:jfab163. doi: 10.1093/jalm/jfab163. Epub ahead of print.
    • Mutations of BRCA1/2 Genes in the West of Turkey and Genotype-Phenotype Correlations.
    • Gun-Bilgic D, Aydin-Gumus A, Bilgic A, Cam FS.
    • Clin Lab. 2022 Jan 1;68(1). doi: 10.7754/Clin.Lab.2021.210425.
    • Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature).
    • Vodolazhsky DI, Mayakovskaya AV, Kubyshkin AV, Aliev KA, Fomochkina II.
    • Klin Lab Diagn. 2021 Dec 21;66(12):760-767. English. doi: 10.51620/0869-2084-2021-66-12-760-767.
    • Review